ISO 20417: The Complete Guide to the 2026 Edition

Introduction

ISO 20417 was revised in March 2026, and most of what has been written about the revision since then describes a standard that does not exist. Gap analyses circulating online list six sweeping changes — a mandatory reading level for lay instructions, label durability turned normative, a brand-new sterile barrier obligation, an eIFU access-control duty. The Foreword of ISO 20417:2026 lists four changes, and none of those four is on it.

That matters because a labelling procedure rewritten against an invented requirement wastes a quarter, and a procedure that misses the real ones fails the next file review. The real changes are narrower and more technical: a deleted escape clause on normative references, a deleted manufacturer-identification item, four cross-reference annexes removed, and a new defined term, applicable policy, that ties the standard to whatever each market’s regulator demands. This guide is built from the text of both editions, and it sits alongside our guides to EU MDR technical documentation and the EU MDR GSPR checklist, where the labelling evidence ultimately has to land.

It covers what the standard governs, which edition applies in the EU and the US and until when, the four changes clause by clause, the claims the text does not support, applicable policy, the end of Clause 4 b), the move from EC REP to EU REP, the label requirements that did not move, the GSPR mapping you now have to own, and six findings worth clearing before an audit.

Table of Contents

What ISO 20417 governs, and what it replaced

ISO 20417 sets the generally applicable requirements for the information a manufacturer supplies with a medical device or accessory: identification, labels, packaging, marking and accompanying information such as the instructions for use and the technical description. Its Scope is explicit that it does not specify the means by which the information is supplied, so paper, on-device marking, a graphical user interface and a website are all in play. It is equally explicit about its rank: the specific requirements of a product standard or group standard take precedence over it. ISO 20417 is the floor that the vertical standards build on, not the ceiling.

The first edition, ISO 20417:2021, superseded EN 1041:2008+A1:2013 in Europe. EN 1041 was a European document built around the Directives; ISO 20417 was drafted in ISO/TC 210 with CEN/CLC/JTC 3 under the Vienna Agreement, so a single text serves the EU, the FDA and every IMDRF-aligned regulator. The 2026 edition keeps that architecture and says so in its Introduction: Clause 4 carries the general process requirements, Clause 5 the information elements that must be established before anything is printed (units, language and country identifiers, dates, full address, model and catalogue numbers, production control identifiers, UDI, use and reuse, sterile state), Clause 6 the requirements for the label, packaging, IFU and technical description, and Clause 7 the information tied to importers, distributors, repackaging, translation and regulatory identification.

A gap analysis works best when it follows that structure rather than a reading order. Clause 5 is where inconsistencies are born — a date format defined one way in the label specification and another in the IFU, a catalogue number that differs between packaging levels — and Clause 6 is where they become visible to a reviewer. Fixing Clause 6 findings without going back to the Clause 5 definitions is how the same nonconformity returns at the next surveillance audit.

The 2026 text is also shorter. ISO lists it at 51 pages; the 2021 edition ran past 70, and most of the difference is the cross-reference annexes that the revision deleted. Shorter does not mean lighter: the requirement clauses are essentially where they were, and what disappeared is the scaffolding many technical files had been leaning on.

Which edition applies, where, and until when

ISO 20417:2026, the second edition, was published in March 2026 and cancels and replaces ISO 20417:2021. CEN adopted it without modification as EN ISO 20417:2026 in April 2026, under the M/575 standardisation request that supports the MDR and IVDR. What it has not done is appear in the Official Journal. Neither EN ISO 20417:2021 nor EN ISO 20417:2026 has been cited in Implementing Decision (EU) 2021/1182 or its IVDR counterpart, and the June 2026 amendment that harmonised the symbol standard left ISO 20417 out.

The practical effect is smaller than it sounds. Because the 2021 edition was never harmonised either, no manufacturer has ever had a presumption of conformity from ISO 20417 to lose. The standard has always been used the same way: as the generally acknowledged state of the art for Annex I, Chapter III of the MDR and IVDR, declared in the GSPR checklist as a non-harmonised standard. That argument only works for the current edition. Citing a cancelled standard as state of the art is a contradiction a reviewer will point out.

The United States moved faster and more formally. The FDA recognised the second edition in full on 25 May 2026 as recognition number 5-149, on recognition list 066, superseding recognition 5-135 for the 2021 edition. Declarations of conformity to the 2021 edition are accepted in premarket submissions until 1 July 2029 and refused after that. Note what this means for a manufacturer that sells in both markets: the FDA deadline is the only hard date attached to ISO 20417 itself, and it is still almost three years away. The EU date that will touch artwork sooner belongs to a different standard, the symbol standard, and Figure 1 puts all of them on one line.

The ISO 20417 transition, date by dateEight dates that decide which edition, which symbol and which eIFU rule applies to a labeltodayISO 15223-1:2021/Amd 1:2025Authorized representative symbol made non-country-specific: [XX] becomesEU, CH and so onMAR 2025Regulation (EU) 2025/1234 in forceeIFU opened to every MDR device for professional users; web address goesinto EUDAMED16 JUL 2025ISO 20417:2026 publishedSecond edition cancels and replaces ISO 20417:2021MAR 2026EN ISO 20417:2026 adopted by CENEuropean adoption without modification. Not cited in the OJEUAPR 2026FDA recognition 5-149Second edition recognised in full on list 06625 MAY 2026EU REP symbol harmonisedEN ISO 15223-1:2021/A1:2025 cited under the MDR by Decision (EU) 2026/123117 JUN 2026TODAYFDA stops accepting 2021 DoCsDeclarations of conformity to recognition 5-135 no longer accepted1 JUL 2029Old EN ISO 15223-1 reference withdrawnLast day the unamended symbol standard gives presumption of conformity17 JUN 2031
Figure 1 — the ISO 20417 transition timeline, from ISO 15223-1 Amendment 1 to the withdrawal of the unamended symbol reference

The current edition can be bought from the ISO catalogue page for ISO 20417. If a national adoption is easier to obtain, BS EN ISO 20417:2026 and the other national EN versions carry identical text.

The ISO 20417 2026 edition changed four things, not six

The Foreword of ISO 20417:2026 states that the second edition has been technically revised and lists the main changes in four lines: the normative references were updated; the former informative Annexes D, F, G and H were deleted; the term applicable policy was added; and item b) in Clause 4 and item d) 1) in 6.1.2 were deleted. That is the complete list. Anything presented as a 2026 change that cannot be traced to one of those four lines is either an editorial rewording inside an existing clause or someone else’s invention.

The normative reference update is more consequential than its one-line entry suggests. The 2021 edition referenced ISO 13485:2016, IEC 62366-1:2015+AMD1:2020, ISO 16142-1:2016, ISO 16142-2:2017, ISO 3864-1:2011 and ISO 8601-1 normatively. All six are gone from Clause 2 of the 2026 text. What remains is ISO 3166-1, ISO 7000, ISO 7010 (now undated), ISO 14971:2019, ISO 15223-1:2021, IEC 60417 and ISO 80000-1, plus one addition: ISO 15223-1:2021/Amd 1:2025, the amendment that rewrote the authorised representative symbol. Clause 3 follows the same line and now imports defined terms from ISO 14971:2019 alone, where the 2021 edition imported them from five standards.

ISO 20417:2026 as a redline of the 2021 textEvery change the 2026 Foreword lists, shown the way a tracked-changes copy would show itClause 4 b)The manufacturer may substitute a more currentversion of a dated normative reference, provided theresidual risk stays acceptable and comparable.Deleted. Datedreferences now apply ascited.Clause 6.1.2 d) 1)Item d) 1) of the manufacturer identificationrequirements.Deleted. Authorizedrepresentative nowfollows ISO 15223-1 Amd1:2025.Clause 3.3applicable policy: set of requirements relating to aproduct and its attributes, established by theauthority having jurisdiction.Added. New definedterm.Clause 2ISO 13485:2016 · IEC 62366-1 · ISO 16142-1 and -2 ·ISO 3864-1 · ISO 8601-1Removed from thenormative references.Clause 2ISO 15223-1:2021/Amd 1:2025Added as a datednormative reference.Annexes D, F, G, HCross-reference tables to ISO 16142 essentialprinciples, MDR GSPR and IVDR GSPR.Deleted. No EU mappingleft in the standard.Annex E → DReference to IMDRF essential principles and labellingguidance, now N47:2024 and N52:2024.Kept and renumbered.DeletedInsertedMoved / renumberedNothing else is listed as a main change. Clause 6.4 durability and Annex C existed in 2021 and Annex C isstill informative.
Figure 2 — the four main changes of ISO 20417:2026 shown as a redline of the 2021 text

The deletion of IEC 62366-1 from the normative references does not mean usability engineering stops mattering for labelling — the MDR still expects the information supplied to be designed for the intended user, and IEC 62366-1 remains the recognised way to show it. It does mean that a labelling SOP which justified its usability activities by pointing to ISO 20417 Clause 2 is now pointing at a reference that is no longer there, and the justification has to rest on the regulation and on IEC 62366-1 directly.

Two smaller edits to the definitions are worth knowing because they reach software. The definition of e-documentation, 3.9, now gives as examples information accessible through an application programming interface where software has no graphical user interface, and machine-readable information such as a software bill of materials. And the label definition, 3.18, keeps its note that information shown on a graphical user interface is considered as appearing on the item. Neither is listed as a main change, but both confirm the direction of travel: the standard treats software-delivered information as labelling, not as an exception to it.

Five claims about the 2026 edition that the text does not support

Several widely shared summaries of ISO 20417:2026 describe changes that do not appear in the Foreword list, and the earlier version of this article repeated some of them. The table sets each claim against what the two editions actually show. Where the full clause text cannot be quoted, the test applied is simple: ISO lists every main technical change in the Foreword, and a requirement that moved from informative to normative, or appeared from nothing, would be on that list.

Claim in circulationWhat the source showsWhat to do instead
Lay-user IFUs must now be written at a “lower secondary education level”Not in the Foreword change list. Lay-user IFU requirements sit in 6.6.3 in both editionsEvidence comprehension through IEC 62366-1 usability evaluation; treat readability scores as supporting data
Label durability moved from an informative annex to a normative requirementClause 6.4 Durability of markings is normative in both editions. Annex C, the example durability test method, is informative in bothKeep the 6.4 evidence you should already have; no new test campaign is triggered by the revision
Sterile barrier configuration is a new labelling requirementNot in the change list. The 2026 text gathers the topic in a separately titled subclause, 6.5.4 Sterile packaging. The underlying EU duty is MDR Annex I 23.3(a)Show that the sterile barrier layer is recognisable as such, typically with the ISO 15223-1:2021 barrier symbols
A new duty to restrict eIFU access by user groupNot in the change list. e-documentation sits in 6.6.5 in both editionsFollow Regulation (EU) 2021/2226 as amended by 2025/1234, including its risk assessment
A new authorised representative symbol, numbered 5.1.12, with no country codeAmendment 1:2025 to ISO 15223-1 modifies the existing symbol: the country part becomes [XX], filled with a code recognised by the jurisdiction, such as EUUse EU REP for the EU representative; a CH-coded variant remains valid where Switzerland recognises it

Two further details from the same summaries are simply wrong on the face of the text. There is no Clause 8.7.4 — the standard ends at Clause 7. And no count of “roughly twenty clauses” using applicable policy can be checked against anything published; what can be checked is the definition itself, which is short and precise and is the subject of the next section.

Before acting on any ISO 20417:2026 gap analysis, read the four-line change list in the Foreword. It takes thirty seconds and filters out most of the remediation work that consultants are currently selling.

Applicable policy turns local rules into a documented input

Clause 3.3 of ISO 20417:2026 defines applicable policy as a set of requirements relating to a product and its attributes, such as form, fit, function, process or information supplied by the manufacturer. Note 1 to the entry says the applicable policy is established by the authority having jurisdiction, defined in 3.4 as the governmental agency or office assigned to oversee regulated products within a country, jurisdiction or territory. Note 2 adds that it can include a specification of the format of the information.

The 2021 edition dealt with jurisdictional differences through scattered notes saying that something could be required by the authority having jurisdiction, and the Scope still carries a note that some authorities impose different requirements. The new term gives those differences a name that a procedure can reference, which is the real point of the change. A manufacturer can now write one labelling procedure against ISO 20417 and state, as a defined input, that each market’s applicable policy is identified and met.

What that looks like in a quality system is a market matrix: one row per information element that varies by jurisdiction, one column per market served. For the EU the policy is MDR or IVDR Annex I, Chapter III, the eIFU implementing regulation and any national language rules; for the US it is 21 CFR Part 801 or Part 809 and the UDI rule; for other markets it is whatever the local regulator publishes. The matrix records, element by element — language, importer identification, date format, UDI presentation, symbol acceptance — which policy applies and where on the label or in the IFU it is met. It belongs in the labelling procedure or as a controlled annex to it, and it is reviewed whenever a market is added or a regulator changes its rules.

None of this creates a new obligation in substance. Every manufacturer selling into the EU and the US already had to meet both sets of rules. What applicable policy removes is the ability to meet them silently. A reviewer can now ask where the applicable policy for each market is identified, and a file that answers with “regulatory affairs knows” has a documentation gap even if every label is correct.

Clause 4 b) is gone: a dated reference now means that edition

Clause 4 b) of ISO 20417:2021 read: where this document specifies a specific edition of a normatively referenced document, the manufacturer may substitute a more current version provided the manufacturer can demonstrate that the residual risk that results from the substitution remains acceptable and is comparable to the residual risk that results from applying the normatively referenced document. It was a flexibility clause, and it was used. Labelling procedures cited it to move to new symbol editions before ISO 20417 caught up, with a short risk argument filed alongside.

The 2026 edition deletes it. Clause 2 of both editions carries the standard ISO wording: for dated references only the edition cited applies, and for undated references the latest edition, including amendments, applies. Without 4 b), there is no longer a route inside ISO 20417 to substitute a newer edition of a dated reference and still claim conformity to ISO 20417 for that point. In practice the impact concentrates on two dated references: ISO 14971:2019 and ISO 15223-1:2021 with its 2025 amendment.

The deletion does not stop a manufacturer from applying a newer edition of a referenced standard. It changes where that decision is documented. Adopting a new symbol edition, for instance, becomes a design and labelling change handled through change control, with its own assessment under the risk management process of ISO 14971, and the GSPR checklist then declares the newer standard directly rather than claiming it as a permitted substitution under ISO 20417. The first audit question will be simple: does any procedure still cite Clause 4 b)? If it does, the citation is to a requirement that no longer exists.

✦ EU MDR Technical Documentation Kit · Annex II, III and IV

Your labelling evidence needs a section a reviewer can find.

Eight Word templates and an Excel master index covering every section of Annex II, the Annex III PMS documentation and the Annex IV Declaration of Conformity, including a labelling and IFU template mapped to Annex I Section 23, so the ISO 20417 evidence sits where Notified Bodies look for it.

✓ TDK-002 Labelling and Instructions for Use, mapped to Annex II Section 2 and Annex I Section 23

✓ TDK-004 GSPR checklist with applied standards and the evidence reference for each requirement

✓ Team-NB notes inline, including when electronic IFU is permitted

Get the Technical Documentation Kit → €429

From EC REP to EU REP: the symbol change that reaches your artwork

The second deleted item, 6.1.2 d) 1), sat in the clause on identification of the manufacturer, where the authorised representative is identified. Its removal goes together with the new normative reference to ISO 15223-1:2021/Amd 1:2025, published in March 2025 under the title Addition of defined term for authorized representative and modified EC REP symbol to not be country or region specific. The amendment does exactly what its title says. It adds a definition of authorised representative and replaces the fixed letters in the symbol with a placeholder, [XX], to be filled with a country code or other text recognised by the jurisdiction concerned.

For the EU the result is EU REP, which also removes the old objection that EC is both an outdated reference to the European Community and the ISO 3166 code for Ecuador. For other jurisdictions that recognise an authorised representative, the same symbol takes the relevant code, for example CH for Switzerland. Whether a given market accepts a coded variant is a question of that market’s applicable policy, which is precisely the kind of point the new defined term is there to capture.

On the EU side the symbol amendment, unlike ISO 20417 itself, is harmonised. Implementing Decision (EU) 2026/1231 cited EN ISO 15223-1:2021/A1:2025 under the MDR in the Official Journal of 17 June 2026, with a parallel IVDR decision, and the reference to the unamended EN ISO 15223-1:2021 is withdrawn from 17 June 2031 after a corrigendum corrected the date. That gives a five-year window. There is no reason to recall stock or relabel product that is already compliant; there is every reason to switch to EU REP on the next revision a label goes through for any other reason, and to stop releasing new artwork with EC REP now. A Notified Body may set its own expectations for the transition, so confirm them at the next audit planning call.

The symbols themselves, and the rest of the amendment, live in ISO 15223-1. The reprocessing information that often shares the same IFU is governed by ISO 17664-1 and -2, covered in our ISO 17664 guide.

The label requirements that did not move, and still fail files

Most of ISO 20417 is unchanged in substance between the two editions, and most of the findings it generates come from that unchanged core. Figure 3 maps a typical sterile pack label to the clauses that govern each field in the 2026 numbering. The numbering matters: the 2026 edition no longer has the separate 5.6 Commercial product name subclause of 2021 — the term survives as a synonym in the catalogue number definition, 3.6 — so subclauses 5.7 to 5.12 of the 2021 edition are now 5.6 to 5.11. A traceability matrix built on the 2021 numbering points to the wrong subclause for model number, catalogue number, production control identifiers, UDI, use and reuse, and sterile state.

Anatomy of a sterile pack label under ISO 20417:2026Each field traced to the clause that governs it. The label is schematic, not a symbolreferenceACME Vascular KitREF AV-2210MFRMaker GmbH, full addressEU REPRep B.V., full addressLOT2611AEXP2029-11-30(01)0XXXXXXXXXXXXX(17)291130(10)2611ASTERILE EObarrierIFUeifu.example.com6.1.3Identification of thedevice6.1.2Manufacturer: name, fulladdress (5.5)ISO 15223-1 Amd 1Authorized representativesymbol5.9Unique device identifier6.1.5 · 6.6.5Consult IFU;e-documentation5.7Catalogue number5.4 · 5.8Dates; production controlIDs5.11 · 6.5.4Sterile state; sterilepackagingTwo clauses apply to every field at once: 6.3 legibility (clearly legible to a person with normal vision) and 6.4durability of markings over the expected lifetime. Annex B and Annex C give informative test methods.
Figure 3 — anatomy of a sterile pack label with each field traced to its ISO 20417:2026 clause

Lay-user instructions: prove comprehension through usability, not adjectives

Clause 6.6.3 carries the additional requirements for instructions for use intended for a lay user, defined in 3.19 as someone without formal education in a relevant field of healthcare and, where appropriate, without specialised training on the specific device. Packaging for the lay user has its own subclause, 6.5.2. These requirements were in the 2021 edition and remain in the 2026 one; the revision did not add a reading-level threshold to them.

The weakness auditors find here is not a missing clause. It is a technical file that asserts the IFU is clear and offers nothing behind the assertion. The defensible approach is to make IFU comprehension one of the tasks in the usability engineering file under IEC 62366-1: representative lay users, in formative and summative evaluation, finding the right instruction, understanding it and acting on it correctly, with the safety-related information treated as critical tasks. Readability formulas such as Flesch-Kincaid or SMOG are useful supporting evidence during drafting, but they measure sentence and word length, not whether a user correctly follows a warning, and they should never be the only evidence in the file.

Durability and sterile packaging: old clauses, new structure

Clause 6.4 Durability of markings requires markings to remain clearly legible over the expected lifetime, and it was normative in 2021 as it is now. Annex C gives an example durability test method and is informative in both editions; Annex B does the same for legibility, which 3.7 defines as capable of being read by a person with normal vision. The expected lifetime itself is defined in 3.11, and the 2026 notes add that it can be expressed as a number of uses or cycles as well as an absolute time. A durability claim that does not cover the cleaning agents, sterilisation cycles or abrasion the device actually sees across that lifetime is the finding, whichever edition is cited.

Sterile packaging now has a separately titled subclause, 6.5.4, where the 2021 edition handled it within the general packaging requirements. The Foreword does not list this as a main technical change, so treat it as restructuring until the clause text in your copy shows otherwise. The obligation that drives the label in the EU is older and sits in the regulation: MDR Annex I 23.3(a), and IVDR Annex I 20.3(a), require an indication permitting the sterile packaging to be recognised as such. Where several packaging layers look alike, the single and double sterile barrier system symbols introduced in ISO 15223-1:2021 are the usual way to show which layer is the barrier.

eIFU and software: the GUI is the label

ISO 20417 has carried requirements for e-documentation in 6.6.5 since 2021; when electronic instructions are allowed is not its decision. In the EU that is governed by Implementing Regulation (EU) 2021/2226, which originally limited eIFU to listed device categories for professional users and required a documented risk assessment. Implementing Regulation (EU) 2025/1234, adopted on 25 June 2025 and in force since 16 July 2025, removed the category list: eIFU is now possible for all MDR devices and accessories intended for professional users, the web address has to be provided to EUDAMED, and where use by lay persons is reasonably foreseeable a paper IFU is still required for them. The risk assessment remains.

For software, the label definition settles the question that software manufacturers keep reopening. Note 3 to 3.18 states that information indicated on a graphical user interface is considered as appearing on the item. The About screen, the help pages and the in-app IFU are labelling, subject to the same identification, legibility and change-control expectations as a printed label. That has three consequences in practice: the UDI and the software version identification have to be reachable from within the application; the warnings and limitations shown in the interface have to trace back to the risk management file like any other information for safety, defined in 3.14 as information provided as a risk control measure; and the release process has to update the in-app content in the same build that changes the behaviour it describes.

✦ MD Regulatory Academy · IEC 62366-1

Lay-user IFU evidence comes out of the usability file.

The IEC 62366-1 course works through the usability engineering process end to end — use specification, hazard-related use scenarios, formative and summative evaluation — including how to treat the instructions for use as part of the user interface you test.

✓ 13 modules and a final test, 2 hours 32 minutes of video

✓ Self-paced, with workbook and verifiable certificate

Get the IEC 62366-1 course → €229

With Annexes G and H deleted, the GSPR mapping is yours to own

The 2021 edition carried nine annexes. Annex D cross-referenced the standard against the requirements considered, Annex E against the IMDRF essential principles and labelling guidance, Annex F against the ISO 16142 essential principles, Annex G against the MDR general safety and performance requirements and Annex H against the IVDR ones. The 2026 edition deletes D, F, G and H and keeps the IMDRF reference, renumbered as Annex D and updated to IMDRF/GRRP WG/N47:2024 and N52:2024. Annex A on guidance and rationale, Annexes B and C on legibility and durability test methods and the index of terms, now Annex E, remain.

Annexes G and H were the convenient bridge. A GSPR checklist could declare ISO 20417 against Annex I, Chapter III and point to Annex G for the clause-by-clause justification. That pointer now leads nowhere. The labelling rows of the checklist — Section 23 of MDR Annex I, Section 20 of IVDR Annex I — need their own mapping to the ISO 20417:2026 clauses that support each requirement, held in the technical documentation and maintained by the manufacturer. Most well-built files already had this mapping internally; files that leaned on the annex have a visible gap, and it is one of the first things a reviewer checks when a standards list has been updated to 2026.

The deletion is defensible. The legacy Directive references in the old cross-reference were dead, and five years into MDR application a Notified Body expects the manufacturer’s own GSPR documentation to stand without a standard’s appendix holding it up. ISO 20417 was also never a complete answer on its own. Full conformity with Chapter III layers in risk management driving the content of warnings, ISO 15223-1 for symbols, ISO 17664-1 and -2 for reprocessing information, the ISO 18113 series for IVD reagents and instruments, which as a group standard takes precedence where it applies, and the eIFU regulation. The mapping has to show all of them, and for IVDs it sits in the IVDR technical documentation rather than the MDR file.

Six findings to clear before the next audit

Every one of the findings below traces back to the same root cause: a procedure, checklist or label that still reflects the 2021 text or an inaccurate summary of the 2026 one. None of them requires new testing. All of them require someone to open the documents and change them.

Six ISO 20417 findings to clear before the next auditWritten as audit tickets: what the reviewer sees, and the fix that closes itTICKET 01MAJORLabelling SOP still uses 2021 Clause4 b)Newer referenced editions substituted on aresidual-risk argument.FIXDelete the clause citation; manage neweditions through change control and the riskfile.TICKET 02MAJORGSPR traceability points to Annex Gor HThe labelling rows of the checklist cite an annexthat no longer exists.FIXMap each Annex I Chapter III row to ISO20417:2026 clauses in your own matrix.TICKET 03MINORDoC and GSPR checklist cite ISO20417:2021A cancelled edition in the standards list.FIXCite ISO 20417:2026; for FDA files, plan theswitch before 1 July 2029.TICKET 04MINORMarket-specific rules undocumentedLanguage, importer and date rules handled by habitper market.FIXRecord each market's applicable policy andwhere the label meets it.TICKET 05MINORSterile barrier not identifiableOuter and inner packs look alike; MDR Annex I23.3(a) not shown.FIXMark the sterile barrier layer, e.g. with theISO 15223-1 barrier symbols.TICKET 06OBSEC REP symbol on new artworkUnamended symbol used on labels revised after June2026.FIXSwitch to EU REP at the next label revision;old reference ends 17 June 2031.
Figure 4 — six ISO 20417 audit findings written as tickets, each with the fix that closes it

The severity assigned in Figure 4 reflects how reviewers typically grade these points rather than any rule. A procedure that relies on a deleted clause and a checklist that relies on a deleted annex both undermine the conformity argument itself, so they tend to be raised as major. A cancelled edition in the standards list, an undocumented applicable policy or an unclear sterile barrier are usually minor if the labels themselves are correct. EC REP on new artwork is an observation today and becomes a nonconformity on 17 June 2031.

✦ Complete catalogue

Find the documentation you need — instantly.

Technical documentation, risk management, clinical, ISO 13485, MDSAP and IVDR kits, all built on Notified Body review experience and ready to drop into an existing quality system.

✓ Editable Word and Excel templates

✓ One-off purchase, instant download

Browse All Kits →

Frequently asked questions

Is ISO 20417:2021 still valid?

No. ISO 20417:2026, the second edition published in March 2026, cancels and replaces it. In the EU the current edition should be cited as state of the art in the GSPR checklist and Declaration of Conformity. The FDA accepts declarations of conformity to the 2021 edition, recognition 5-135, in premarket submissions until 1 July 2029.

What changed in ISO 20417:2026?

The Foreword lists four main changes: the normative references were updated, including the addition of ISO 15223-1:2021/Amd 1:2025; the informative Annexes D, F, G and H were deleted; the term applicable policy was added; and item b) in Clause 4 and item d) 1) in 6.1.2 were deleted.

Is ISO 20417 harmonised under the EU MDR or IVDR?

No. EN ISO 20417:2026 was adopted by CEN in April 2026, but it has not been cited in the Official Journal, and the 2021 edition never was either. ISO 20417 has always been used as the state of the art for Annex I, Chapter III, declared as a non-harmonised standard in the GSPR checklist.

What is applicable policy in ISO 20417?

Applicable policy is defined in Clause 3.3 of ISO 20417:2026 as a set of requirements relating to a product and its attributes, such as form, fit, function, process or information supplied by the manufacturer. It is established by the authority having jurisdiction and can specify the format of the information.

Does ISO 20417 require IFUs at a lower secondary education reading level?

That requirement is not among the changes listed in the Foreword of ISO 20417:2026. Lay-user IFU requirements are in Clause 6.6.3 in both editions. The strongest evidence of comprehension is lay-user usability testing under IEC 62366-1, with readability scores used only as supporting data.

Do I have to replace the EC REP symbol now?

Not immediately. ISO 15223-1:2021/Amd 1:2025 replaces it with EU REP, and the amendment was harmonised under the MDR on 17 June 2026. The unamended reference is withdrawn from 17 June 2031, so switch to EU REP at the next label revision and stop creating new artwork with EC REP.

Does ISO 20417 apply to software as a medical device?

Yes. ISO 20417 does not specify the means by which information is supplied, and Note 3 to the label definition states that information shown on a graphical user interface is considered as appearing on the item. In-app IFUs, About screens and help pages are labelling.

Conclusions

ISO 20417:2026 is a quieter revision than its reputation. It did not change what belongs on a label or in an IFU. It removed an escape clause, removed the annexes many files used as a GSPR shortcut, aligned the authorised representative with a symbol that is now harmonised, and gave market-specific requirements a defined name. The work it creates is documentary, and it is quick: update the standards list, delete any reliance on Clause 4 b), build your own Chapter III mapping, write down each market’s applicable policy, and put EU REP into the next artwork cycle.

The bigger risk this year is not the revision but the commentary around it. A team that rebuilds its IFU process around a reading level the standard does not set, or launches a durability test campaign for a clause that did not change, spends real budget and still leaves the four genuine gaps open. Check every claimed change against the Foreword before you act on it, and check every clause number against the 2026 numbering before it goes into a matrix.

The EU MDR Technical Documentation Kit on MD Regulatory gives you the Annex II structure the labelling evidence belongs in, including the labelling and IFU template mapped to Annex I Section 23 and the GSPR checklist that ties each ISO 20417 clause to a specific requirement — ready to use in an existing ISO 13485 quality management system.

Related articles